Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
590.26
-2.25 (-0.38%)
At close: Oct 22, 2026

EGX:CPCI Financials Overview

Millions EGP. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
2,3932,0791,3611,0051,1121,062
Revenue Growth
30.30%52.80%35.38%-9.61%4.71%5.11%
Gross Profit
840.33791.47517.66237.3326.95268.13
Operating Income
627.16567.86285.6776.74192.08156.33
Net Income
504.49443.72246.1197.09165.74124.3
Earnings Per Share
33.7829.7116.486.5011.108.32
EPS Growth
25.16%80.29%153.48%-41.42%33.34%13.89%

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingMar '26 Jun '25 Jun '24 Jun '23
Egypt
2,1671,8561,254896.12
Sudan
32.2333.9830.3719.22
Jordan
11.7221.0613.927.44
Yemen
39.4342.1620.3923.86
Iraq
31.5362.9312.4134.18
Djibouti
-0.270.37-
Somalia
16.2213.516.759.76
South Sudan
-0.740.560.45
Mali
--0.790.26
Libya
25.5843.3112.827.23
Nigeria
-0.681.4-
Senegal
--3.41.68
Total
2,3242,0751,3571,002

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
73.64171.22168.28139.38111.87146.76
Total Debt
168.29221.78237.53164.2758.36-
Net Cash (Debt)
-94.65-50.57-69.25-24.8853.52146.76
Net Cash Growth
-----63.53%79.29%
Net Cash Per Share
-6.34-3.39-4.64-1.673.589.83

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
212.81378.72262.8988.5351.83162.25
Capital Expenditures
-59.12-139.47-216.24-79.07-17.31-23.68
Free Cash Flow
153.7239.2546.659.4534.52138.57
Free Cash Flow Growth
-41.44%412.87%393.48%-72.61%-75.09%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
35.12%38.06%38.04%23.61%29.40%25.25%
Operating Margin
26.21%27.31%20.99%7.63%17.27%14.72%
Pretax Margin
27.04%27.64%23.17%12.69%19.25%15.35%
Profit Margin
21.08%21.34%18.09%9.66%14.90%11.70%
FCF Margin
6.42%11.51%3.43%0.94%3.10%13.05%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Dividend Per Share
16.74016.74012.8305.0005.0004.000
Dividend Per Share Growth
30.48%30.48%156.60%0%25.00%49.25%
Dividend Yield
2.84%9.34%19.21%11.73%13.54%11.09%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
17.476.034.056.563.334.33
Forward PE
-6.226.226.226.226.22
P/FCF Ratio
57.3511.1821.3867.3515.983.89
PS Ratio
3.681.290.730.630.500.51